Patent Assignment
Reel/Frame 011648/0035
Security Agreement
Recorded: 2001-04-10
Pages: 15
Assignor
CALYDON, INC.
Executed: 2001-03-30
Assignee
PERSEUS CAPITAL, L.L.C.
SUITE 900, 2099 PENNSYLVANIA AVENUE, N.W., WASHINGTON, DISTRICT OF COLUMBIA, 20006
Covered Properties
(25)
Tissue-Specific Enhancer Active in Prostate
Patent:
5,830,686 →
Application:
08/182,247 →
Tissue-Specific Enhancer Active in Prostate
Patent:
5,648,478 →
Application:
08/380,916 →
Tissue Specific Viral Vectors
Patent:
5,698,443 →
Application:
08/495,034 →
Tissue Specific and Tumor Growth Supperssion by Adenovirus Comprising Prostate Specific Antigen
Patent:
5,871,726 →
Application:
08/669,753 →
Prostate Cancer Drug Screening
Patent:
5,783,435 →
Application:
08/692,759 →
Tissue-Specific Enhancer Active in Prostate
Patent:
6,057,299 →
Application:
08/721,690 →
Prostate Specific Enhancer Polynucleotides and Methods of Use Thereof
Patent:
6,136,792 →
Application:
08/891,581 →
Prostate Cancer Drug Screening Using HKLK2 Enhancer
Patent:
6,051,417 →
Application:
08/906,192 →
Adenovirus Vectors Specific for Cells Expressing Androgen Receptor and Methods of Use Thereof
Patent:
6,197,293 →
Application:
09/033,333 →
Adenovirus Vectors Specific for Cells Expressing Alpha-Fetoprotein and Methods of Use Thereof
Patent:
6,254,862 →
Application:
09/033,428 →
Adenovirus Vectors Specific for Cells Expressing Carcinoembryonic Antigen and Methods of Use Thereof
Application:
09/033,555 →
Adenovirus Vectors Containing Heterologous Transcription Regulatory Elements and Methods of Using Same
Patent:
6,432,700 →
Application:
09/033,556 →
Human Glandular Kallikrein Enhancer, Vectors Comprising the Enhancer and Methods of Use Thereof
Application:
09/127,834 →
Tissue Specific Adenoviral Vectors
Adenovirus Vectors Containing Cell Status-Specific Response Elements and Methods of Use Thereof
Methods of Enhancing Effectiveness of Therapeutic Viral Immunogenic Agent Administration
Patent:
6,406,861 →
Application:
09/413,044 →
Tissue-Specific Enhancer Active in Prostate
Application:
09/448,321 →
Target Cell-Specific Adenoviral Vectors Containing E3 and Methods of Use Thereof
Patent:
6,495,130 →
Application:
09/474,699 →
Adenovirus Vectors Specific for Cells Expressing Alpha-Fetoprotein and Methods of Use Thereof
Patent:
7,011,976 →
Application:
09/509,591 →
Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof
Application:
09/593,308 →
Adenovirus Vectors Specific for Cells Expressing Androgen Receptor and Methods of Use Thereof
Patent:
6,436,394 →
Application:
09/614,495 →
Human urothelial cell specific uroplakin transcriptional regulatory sequences, vectors comprising a uroplakin-specific transcriptional regulatory sequences, and methods of use thereof
Application:
60/191,861 →
Methods of Treating Neoplasia with Combinations of Target Cell-Specific Adenovirus, Chemotherapy and Radiation
Application:
60/192,015 →
Cell-Specific Adenovirus Vectors Comprising an Internal Ribosome Entry Site
Application:
60/192,156 →
Rapid methods and kits for detection and semi-quantitation of anti-adenovirus antibody
Application:
60/214,768 →
Related Assignments
(20)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 16, 1996
From: HENDERSON, DANIEL ROBERT; SCHUUR, ERIC RODOLPH
To: CALYDON
Reel/Frame 008135/0877 →
Assignment of Assignor's Interest
Oct 15, 1996
From: LAMPARSKI, HENRY G.; SCHUUR, ERIC RODOLPH; HENDERSON, DANIEL R.
To: CALYDON
Reel/Frame 008184/0119 →
Assignment of Assignor's Interest
Jan 13, 1997
From: HENDERSON, DANIEL R.
To: CALYDON
Reel/Frame 008712/0132 →
Assignment of Assignor's Interest
Sep 17, 1999
From: LITTLE, ANDREW S.; HENDERSON, DANIEL R.; SCHUUR, ERIC R.; LAMPARSKI, HENRY
To: CALYDON, INC.
Reel/Frame 010235/0455 →
Assignment of Assignor's Interest
Dec 20, 1999
From: HENDERSON, DANIEL R.; YU, CHEN; YU, DE CHAO
To: CALYDON, INC.
Reel/Frame 010505/0226 →
Assignment of Assignor's Interest
Jan 12, 2000
From: YU, DE CHAO; HENDERSON, DANIEL R.
To: CALYDON, INC.
Reel/Frame 010510/0232 →
Assignment of Assignor's Interest
Feb 15, 2000
From: HENDERSON, DANIEL R.; SCHUUR, ERIC R.; LAMPARSKI, HENRY S.; YU, DE CHAO
To: CALYDON, INC.
Reel/Frame 010613/0797 →
Assignment of Assignor's Interest
Apr 17, 2000
From: HENDERSON, DANIEL R.; YU, DE CHAO
To: CALYDON, INC.
Reel/Frame 010764/0417 →
Assignment of Assignor's Interest
Aug 14, 2000
From: CHARLTON, DAVID
To: CALYDON, INC.
Reel/Frame 011083/0973 →
Assignment of Assignor's Interest
Dec 5, 2000
From: LITTLE, ANDREW S.; LAMPARSKI, HENRY G.; HENDERSON, DANIEL R.; SCHUUR, ERIC R.
To: CALYDON, INC.
Reel/Frame 011350/0643 →
Assignment of Assignor's Interest
Dec 17, 2001
From: CALYDON, INC
To: CELL GENESYS, INC
Reel/Frame 012243/0012 →
Assignment of Assignor's Interest
Apr 15, 2004
From: CALYDON, INC.
To: CELL GENESYS, INC.
Reel/Frame 014521/0959 →
Assignment of Assignor's Interest
Feb 2, 2010
From: CELL GENESYS, INC.
To: BIOSANTE PHARMACEUTICALS, INC.
Reel/Frame 023973/0005 →
Assignment of Assignor's Interest
Dec 10, 2010
From: BIOSANTE PHARMACEUTICALS, INC.
To: COLD GENESYS, INC.
Reel/Frame 025470/0885 →
Assignment of Assignor's Interest
Dec 22, 2010
From: CELL GENESYS, INC.
To: BIOSANTE PHARMACEUTICALS, INC.
Reel/Frame 025561/0460 →
Assignment of Assignor's Interest
Dec 27, 2010
From: BIOSANTE PHARMACEUTICALS, INC.
To: COLD GENESYS, INC.
Reel/Frame 025568/0888 →
Assignment of Assignor's Interest
Dec 27, 2010
From: BIOSANTE PHARMACEUTICALS, INC.
To: COLD GENESYS, INC.
Reel/Frame 025537/0764 →
Acceptance of Patent Rights
Apr 26, 2011
From: BIOSANTE PHARMACEUTICALS, INC.
To: COLD GENESYS, INC.
Reel/Frame 026181/0163 →
Acceptance of Patent Rights
Apr 26, 2011
From: BIOSANTE PHARMACEUTICALS, INC.
To: COLD GENESYS, INC.
Reel/Frame 026180/0885 →
Change of Name
Nov 9, 2020
From: COLD GENESYS, INC.
To: CG ONCOLOGY, INC.
Reel/Frame 054362/0411 →